Condition
Male Pattern Hair Loss
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
P 1 (1)
P 2 (4)
Trial Status
Completed4
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06692465Phase 2Completed
To Evaluate the Efficacy and Safety of GT20029 Solution in the Treatment of Androgenetic Alopecia (AGA) in Chinese Adult Males
NCT05218642Phase 2Completed
To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia
NCT03852992Phase 2WithdrawnPrimary
Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia
NCT04435847Phase 1CompletedPrimary
Safety and Efficacy of HST 001 in Male Pattern Hair Loss
NCT02170662Phase 2CompletedPrimary
Topical Bimatoprost Effect on Androgen Dependent Hair Follicles
Showing all 5 trials